IMI to hold third-quarter 2003 webcast and conference call on November 13
November 07 2003 - 7:30AM
PR Newswire (US)
IMI to hold third-quarter 2003 webcast and conference call on
November 13 TORONTO, Nov. 7 /PRNewswire-FirstCall/ -- IMI
International Medical Innovations Inc. (TSX:IMI, Amex:IME) will
conduct a live webcast and conference call Thursday, November 13 at
10:30 a.m. to report its operating results and provide a corporate
strategic update for the third fiscal quarter of 2003. The
conference call, which will be open to the general public, will be
chaired by IMI's President and CEO, Dr. Brent Norton, and will
include Ron Hosking, Vice President and CFO, and Andrew Weir,
Director, Communications. Date: Thursday, November 13, 2003 Time:
10:30 a.m. ET Web cast: http://www.imimedical.com/ Conference Call
Numbers: (416) 695-5806 (Toronto area) (800) 273-9672 (North
America toll free) Please call five minutes prior to the start time
and specify the IMI call chaired by Dr. Brent Norton. Following its
completion, a replay of the call can be accessed for three months
on the IMI web site (http://www.imimedical.com/), or for one week
by dialing (416) 695-5800 or (800) 408-3053 (U.S. & Canada) and
entering access code 1494990. IMI is a world leader in predictive
medicine, dedicated to developing rapid, non-invasive tests for the
early detection and monitoring of life- threatening diseases,
particularly cardiovascular disease and cancer. IMI's lead product
is a non-invasive skin test for coronary artery disease. IMI's
cancer products in development include ColorectAlert(TM), a
screening test for colorectal cancer, LungAlert(TM), a screening
test for lung cancer, and a new test for breast cancer. For further
information, please visit the company's web site at
http://www.imimedical.com/. DATASOURCE: IMI International Medical
Innovations Inc. CONTACT: Andrew Weir, Director, Communications,
(416) 222-3449 x27,
Copyright